Qiming Venture Partners
Motao Sun is a healthcare investor currently serving as Vice President at Qiming Venture Partners since July 2019, previously holding the position of Associate. Prior experience includes working as a Senior Analyst in the Optum healthcare management consulting team at UnitedHealth Group from June 2016 to June 2019, and completing internships in Global Regulatory Affairs at CooperCompanies and within the FDA's Inspection Team, where oversight of drugs across over 100 healthcare facilities was a key responsibility. Additionally, Motao Sun has a background in research, having participated in the CSST Program at UCLA with a 4.0 GPA, and served as a Research Assistant at the Queensland Brain Institute. Academic qualifications include a Master's Degree in Public Health from Yale University and a Bachelor of Science in Pharmaceutical Sciences from Fudan University, complemented by an exchange year in Pharmaceutical Sciences at National Taiwan University.
This person is not in any teams
Qiming Venture Partners
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston and the San Francisco Bay Area. Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with over $5.6 billion assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.